…e phenotyping, and DC sorting. DCs from primary and ACT escaped tumors were assessed for T cell activation function and subjected for …
All extracted diseases
Showing 121–180 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Articles mentioning diseases
23,712 articles · page 338 of 1976…or-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted …
…TILs) has shown remarkable and durable anti-tumour responses in metastatic melanoma, even in patients unresponsive to immune checkpoint inhibitors.…
…es, activity in rGBM has been disappointing. Emerging data from melanoma, lung, and renal cancers suggest that treatment-induced or dise…
…Background Biliary tract cancer (BTC) has a dismal prognosis with a 5-year survival rate of onl…
…Background Malignant pleural mesothelioma (MPM) is an aggressive malignancy with a poor prognosis and limited t…
…urther studies are needed to explore ctDNA’s role in monitoring melanoma severity.…
…l cancers including clear cell renal cell carcinoma (ccRCC) and soft tissue sarcoma (STS). 1 2 Yet, many TLS-positive tumors remain resistant, sugg…
…urther studies are needed to explore ctDNA’s role in monitoring melanoma severity.…
…rafusp alfa (BA) + nogapendekin alfa inbakicept-pmln (N-803) in castration-resistant prostate cancer (CRPC). Annals of Oncology, Volume 35, S984 - S985.Redman J, Ma…
…RAS-VAX with nivolumab and ipilimumab in patients with MMRp/MSS mCRC refractory to fluoropyrimidines, irinotecan, and oxaliplatin. P…
…el clinical trial ( NCT04495153), 41 patients with stage III/IV NSCLC with progressive disease despite ICI received per protocol trea…